1[1]Sharma P,Sampliner RE,Camargo E.Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.Am J Gastroenterol 1997;92:582-585.
2[2]Cooper BT,Neumann CS,Cox MA,et al.Continuous treatment with omeprazole 20 mg daily for up to 6 years in Barrett's oesophagus.Aliment Pharmacol Ther 1998;12:893-897.
3[3]Blazeby JM,Farndon JR,Donovan J,et al.A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma.Cancer 2000;88:1781-187.
4[4]Weston AP,Sharma P.Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.Am J Gastroenterol 2002;97:2998-3006.
5[5]Franchimont D,Van Laethem JL,Deviere J.Argon plasma coagulation in Barrett's esophagus.Gastrointest Endosc Clin N Am 2003;13:457-466.
6[6]Faigel DO,Lieberman DA,Weinstein WM,et al.Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus.Gastrointest Endosc 2002;55:23-26.
7[7]Sharma P,Bhattacharyya A,Garewal HS,et al.Durability of new squamous epithelium after endoscopic reversal of Barrett's esophagus.Gastrointest Endosc 1999;50:159-164.
9[9]Ortner MA,Zumbusch K,Liebetruth J,et al.Is topical deltaaminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study.Endoscopy 2002;34:611-616.
10[10]Overholt BF,Panjehpour M,Haydek JM.Photodynamic therapy for Barrett's esophagus:follow-up in 100 patients.Gastrointest Endosc1999;49:1-7.
